
Mount Sinai Launches Center for Artificial Intelligence in Children's Health to Advance AI-Driven Outcomes in Children
New York, NY, March 24, 2025 (GLOBE NEWSWIRE) -- The Icahn School of Medicine at Mount Sinai has launched the Center for Artificial Intelligence (AI) in Children's Health, the first dedicated center of its kind in New York City—a pioneering initiative that aims to improve health care outcomes for children using AI. The Center will develop AI-powered solutions to enhance diagnostics, personalize treatments, and optimize health care delivery for youth and adolescents. Benjamin S. Glicksberg, PhD, an expert in digital health and clinical informatics, will lead the Center.
'The Center for AI in Children's Health underscores Mount Sinai's commitment to pioneering AI-driven technologies that will enable Mount Sinai to deliver world-class care to our children,' said Brendan G. Carr, MD, MA, MS, Chief Executive Officer and Professor and Kenneth L. Davis, MD, Distinguished Chair, Mount Sinai Health System. 'As one of the first centers of its kind in New York City and nationwide, this unique and groundbreaking initiative positions Mount Sinai at the forefront of innovation in health care. Our kids are our future, and under Dr. Glicksberg's leadership, the Center for AI in Children's Health will advance children's health outcomes for generations to come.'
Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean at the Icahn School of Medicine at Mount Sinai and President for Academic Affairs of the Mount Sinai Health System, said, 'The establishment of the Center for Artificial Intelligence in Children's Health exemplifies Mount Sinai's dedication to integrating cutting-edge technologies into patient care. By harnessing the power of AI, we are offering more precise diagnostics and personalized treatments for our youngest patients. With Dr. Glicksberg at the helm, this new center will be instrumental in shaping the future of pediatric medicine as we take bold steps toward innovation and excellence in health care for the next generation.'
Dr. Glicksberg, who will also serve as Associate Professor of Artificial Intelligence and Human Health at the Icahn School of Medicine at Mount Sinai, said, 'While AI has advanced at a remarkable pace in many areas of medicine, pediatric medicine has unfortunately lagged due to stricter privacy considerations, more complicated regulatory pathways, and limited data infrastructure. This new Center is dedicated to addressing these challenges by safely developing, testing, and embedding AI directly into child health care—enabling earlier diagnoses, preventive measures, computer-augmented imaging for complex conditions, expedited drug discovery, and highly personalized treatment plans. There's no better place for this effort than Mount Sinai, or a more talented team of researchers to innovate alongside. I'm thrilled to lead this critical work and confident that we're shaping a brighter future for child health care.'
AI continues to transform health care, however innovation remains significantly underrepresented in child health due to specific standards necessary, but complex regulatory challenges and limited resources, delaying the benefits these technologies could bring to child health care. The Center hopes to address the current limitations by creating an integrated data infrastructure, advancing multimodal AI research, embracing personalized medicine, and enhancing health economics and care delivery.
The Center will focus on:
Building an AI-driven Children's Health Data Hub to unify multi-modal and multi-omic patient data.
Spearheading clinical trials for AI approaches to enhance diagnostics, predictive modeling, and real-time monitoring at Mount Sinai Kravis Children's Hospital.
Advancing personalized medicine through multi-omics research, rare disease identification, and pharmacogenomics.
Optimizing health care delivery with Mount Sinai's Center for Child Health Services Research to leverage AI for improving efficiency, patient outcomes, and resource allocation.
Dr. Glicksberg joins Mount Sinai with significant academic and industry experience. He previously was an Assistant Professor in Genetics and Genomic Sciences and a member of the Hasso Plattner Institute for Digital Health at Mount Sinai. He then served on the leadership team at a genomics-based drug discovery startup targeting progressive diseases of aging. His experience bridging the gap between research and clinical care—including expertise in AI-driven research, health care, biotechnology, and translational science—positions him as a leader in AI innovation.
The Center for Artificial Intelligence in Children's Health is established under The Mindich Child Health and Development Institute, directed by Bruce D. Gelb, MD, and co-sponsored by the Windreich Department of Artificial Intelligence and Human Health at Mount Sinai, chaired by Girish N. Nadkarni, MD, MPH, CPH.
'As Chair of the Windreich Department of AI and Human Health, I'm proud to co-sponsor the Center for AI in Children's Health,' Dr. Nadkarni said. 'By harnessing the power of advanced data science and clinical expertise, we aim to usher in a new era for child health care—delivering faster diagnoses, personalized treatments, and transformative outcomes. Under Dr. Glicksberg's leadership, we stand poised to shape a healthier future for children everywhere.'
About The Mindich Child Health and Development Institute
The Mindich Child Health and Development Institute is a translational research enterprise with the mission of advancing knowledge and therapies for diseases affecting infants, children, and adolescents.
Led by Bruce D. Gelb, MD, the Institute assembles outstanding physician-scientists and scientists in an intellectually rich and supportive environment, which fosters collaborative scientific investigation as well as the training of the next generation of scientific leaders for pediatric medicine. We currently have more than 100 faculty members who specialize in allergy and asthma, cardiovascular disease, neurodevelopmental disorders, obesity and diabetes, child health services, and more.
Faculty at the Institute work in a multidisciplinary manner with researchers and physicians in departments and institutes at Mount Sinai. Together, we strive toward the objectives of developing robust paradigms for understanding the effects of genetics and the environment on the health of infants, children, and adolescents, and personalizing pediatric medicine through genetics and genomics. In addition, we have taken substantial steps in expanding our reach in five exciting strategic areas: pediatric precision medicine; pediatric clinical trials; child health services research; artificial intelligence in children's health; and community-based research engagement.
About Mount Sinai's Windreich Department of AI and Human Health
Led by Girish N. Nadkarni, MD, MPH—an international authority on the safe, effective, and ethical use of AI in health care—Mount Sinai's Windreich Department of AI and Human Health is the first of its kind at a U.S. medical school, pioneering transformative advancements at the intersection of artificial intelligence and human health.
The department is committed to leveraging AI in a responsible, effective, equitable, and safe manner to transform research, clinical care, education, and operations. By bringing together world-class AI expertise, cutting-edge infrastructure, and unparalleled computational power, the department is advancing breakthroughs in multi-scale, multimodal data integration while streamlining pathways for rapid testing and translation into practice.
The department benefits from dynamic collaborations across Mount Sinai, including with the Hasso Plattner Institute for Digital Health at Mount Sinai—a partnership between the Hasso Plattner Institute for Digital Engineering in Potsdam, Germany, and the Mount Sinai Health System—which complements its mission by advancing data-driven approaches to improve patient care and health outcomes.
At the heart of this innovation is the renowned Icahn School of Medicine at Mount Sinai, which serves as a central hub for learning and collaboration. This unique integration enables dynamic partnerships across institutes, academic departments, hospitals, and outpatient centers, driving progress in disease prevention, improving treatments for complex illnesses, and elevating quality of life on a global scale.
In 2024, the Department's innovative NutriScan AI application, developed by the Mount Sinai Health System Clinical Data Science team in partnership with Department faculty, earned Mount Sinai Health System the prestigious Hearst Health Prize. NutriScan is designed to facilitate faster identification and treatment of malnutrition in hospitalized patients. This machine learning tool improves malnutrition diagnosis rates and resource utilization, demonstrating the impactful application of AI in health care.
About the Hasso Plattner Institute at Mount Sinai
At the Hasso Plattner Institute for Digital Health at Mount Sinai, the tools of data science, biomedical and digital engineering, and medical expertise are used to improve and extend lives. The Institute represents a collaboration between the Hasso Plattner Institute for Digital Engineering in Potsdam, Germany, and the Mount Sinai Health System.
Under the leadership of Girish Nadkarni, MD, MPH, who directs the Institute, and Professor Lothar Wieler, a globally recognized expert in public health and digital transformation, they jointly oversee the partnership, driving innovations that positively impact patient lives while transforming how people think about personal health and health systems.
The Hasso Plattner Institute for Digital Health at Mount Sinai receives generous support from the Hasso Plattner Foundation. Current research programs and machine learning efforts focus on improving the ability to diagnose and treat patients.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals, more than 400 outpatient practices, more than 600 research and clinical labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients' medical and emotional needs at the center of all treatment. The Health System includes approximately 9,000 primary and specialty care physicians and 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Hospitals within the System are consistently ranked by Newsweek 's® 'The World's Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals' and by U.S. News & World Report 's® 'Best Hospitals' and 'Best Children's Hospitals.' The Mount Sinai Hospital is on the U.S. News & World Report ® 'Best Hospitals' Honor Roll for 2024-2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights
TeleTracking Technologies, a leading provider of healthcare operations platforms, has teamed up with Palantir Technologies Inc. (NASDAQ:PLTR), known for its expertise in artificial intelligence systems. The two companies have formed a strategic partnership with the goal of transforming how hospitals and health systems make operational decisions, ultimately creating long-term value for healthcare providers around the world. The collaboration will integrate TeleTracking's Operations IQ platform with Palantir Technologies Inc. (NASDAQ:PLTR)'s AI-driven tools, including Foundry and AIP. This combined solution is expected to equip hospitals with near real-time, actionable insights to improve staffing efficiency, speed up decision-making, and ensure that patient needs remain the top priority. As healthcare systems continue to face increasing demands to enhance capacity and coordination without expanding their physical footprint, this partnership represents a significant step forward. By bringing together TeleTracking's operational strengths and Palantir Technologies Inc. (NASDAQ:PLTR)'s cutting-edge technology, the two aim to usher in a new era of intelligent, scalable, and efficient healthcare delivery. Alex Karp, CEO at Palantir Technologies Inc. (NASDAQ:PLTR) made the following comment: 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach, helping to streamline operations allowing for increased focus on providing the best level of care.' Palantir Technologies Inc. (NASDAQ:PLTR) is an American publicly traded company that focuses on developing software platforms designed for analyzing large volumes of data. While we acknowledge the potential of PLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Associated Press
12 hours ago
- Associated Press
Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence
06/06/2025, Miami, Florida // PRODIGY: Feature Story // Anna Forsythe, founder of Oncoscope-AI (source: Oncoscope-AI) Oncoscope-AI, a revolutionary oncology intelligence platform, has officially launched following a successful beta phase and over a year of strategic development that involved extensive conversations with practicing oncologists. The platform, which delivers real-time, human-curated cancer insights enhanced by artificial intelligence, is now live and available free of charge to verified healthcare professionals worldwide. Founded by Anna Forsythe, a pharmacist, health economist, and seasoned pharmaceutical executive, Oncoscope addresses a critical gap in oncology care. It gives clinicians instant access to the most current treatment data, FDA approvals, and guideline-aligned information, consolidated into one user-friendly platform. 'Doctors do not need more data. They need the right information, at the right time, in a format they can use to make better decisions for their patients,' said Forsythe. 'Oncoscope provides that clarity. It is a living library of oncology, curated by experts and built to save lives.' Unlike generic AI tools or static databases, Oncoscope uses trained AI to scan thousands of oncology publications and filters them through a rigorous, evidence-based framework. Each entry is cross-referenced with clinical guidelines and regulatory approvals to ensure usability and relevance. All of the results are carefully scrutinized by a team of experienced researchers. Currently, the platform supports breast and lung cancer, with prostate, bladder, colon, and rectal modules rolling out in the coming months. The process is intuitive. Physicians answer three clinical questions—cancer stage, genetic markers, and prior treatments—and receive a personalized, actionable summary. Each recommended article includes survival data, progression insights, treatment efficacy, and toxicity, extracted across 32 key clinical parameters. 'The result is something physicians can actually use in the moment,' said Forsythe. 'It takes three clicks to go from a patient in the room to the most up-to-date evidence in the field.' Access to Oncoscope is free for verified healthcare professionals, including physicians, nurses, pharmacists, genetic counselors, and physician assistants. Non-verified users, such as those in finance or consulting, can purchase limited access at a monthly rate, restricted to a single cancer type. This structure reflects the company's commitment to empowering front-line clinicians with better tools—without barriers. Forsythe, who previously founded and sold a successful health economics company serving global pharmaceutical clients, brings a rare combination of clinical, technical, and business expertise to this venture. She sees Oncoscope not only as a tool, but as a mission. 'This platform was born from both professional insight and personal urgency,' she said. 'Too many patients are still receiving outdated treatments, simply because their doctors do not have time to stay current. I realized I had the knowledge, the team, and the experience to fix that.' With a lean team, strategic vision, and a rapidly growing user base, Oncoscope is poised to become a trusted global resource in cancer treatment. 'We are not just a tech company,' said Forsythe. 'We are part of the oncology ecosystem. And we are here to help doctors deliver the best care possible.' For more information, visit Media Contact: Name - Anna Forsythe Email - [email protected] Source published by Submit Press Release >> Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence


TechCrunch
12 hours ago
- TechCrunch
Meet the Finalists: VivaTech's 5 Most Visionary Startups of 2025
Narrowing down the 30 most visionary startups of the year to just five finalists was no easy feat. VivaTech's Innovation of the Year attracted an extraordinary pool of applicants—startups tackling massive global challenges with bold, technically sophisticated, and scalable solutions. From redefining human-machine interaction to revolutionizing healthcare, climate, and infrastructure, each company brought something unique to the table. The selection process was intense, and every startup that made it to the top 30 should be incredibly proud of what they've built. VivaTech Innovation of the Year is debuting this year to celebrate and spotlight the trailblazing startups that are reshaping the future. This prestigious award is open to all exhibiting startups at VivaTech 2025 and recognizes one startup that has demonstrated exceptional creativity, technological ingenuity, and the potential to transform its industry. Now, we're excited to reveal the five finalists who will take the stage live at VivaTech 2025: BeyondMath: the world's first generative physics platform, replacing slow, expensive simulations with real-time, AI-powered physics. Engineers can run 1000x faster simulations, test thousands of designs instantly, and cut time, cost, and complexity. Chipiron: building the first light, low-cost MRI using ultra-low magnetic fields without sacrificing image quality. Their goal: make MRI 100x more accessible and enable early, large-scale screening—like a blood test for everyone. Enerdrape: offers the world's first non-invasive geothermal panels that transform underground spaces—like car parks and tunnels—into renewable heating and cooling sources, enabling fast, low-carbon retrofits without drilling in dense urban environments. Hua Tech International: an automated microfluidic platform integrating a nanostructured semiconductor biochip, multiplex fluorescence staining, and AI analysis to precisely capture, identify, and analyze rare circulating cells for cancer diagnostics. Techcrunch event Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA | REGISTER NOW Lumisync: data centers to synchronize their data flow at the speed of light with the world's 1st 100% photonic oscillator to reduce their latency and energy consumption by 1000x. These standout companies will pitch their solutions during the Final of the VivaTech Innovation of the Year on Wednesday, June 11th at 1:35 PM, live on the Pitch Studio Stage. Each pitch will be followed by a Q&A session with a panel of expert judges including TechCrunch's own Jeff Taylor, Jaja Liao of 25madison, Shabir Vasram of Daphni and Howard Wright of NVIDIA. The winner of Innovation of the Year will be announced the following day at the VivaTech Global Awards Ceremony on Thursday, June 12th at 5:45 PM on Stage 1. In addition to the title, the winning startup will receive a free Startup Corner at VivaTech 2026 and a coveted spot in the TechCrunch Startup Battlefield 200. The Ceremony will also spotlight the four other VivaTech Awards and announce the winners of each. The Female Founder Challenge, celebrating the women leading innovative startups that are driving the disruptive technologies shaping the future. The Africatech Awards, this pan-African initiative recognizes and supports startups striving to make a positive impact in three important areas – GreenTech, HealthTech, and E-commerce / FinTech. The Next Startupper Challenge, the inter-school and university award for the new generation of entrepreneurs working on impactful projects to make their dreams a reality. The Tech For Change Award, launched this year alongside VivaTech Innovation of The Year, recognizing startups that place positive impact at the heart of their business model. Stay tuned—we can't wait to see these groundbreaking founders take the spotlight.